AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

JUDGES SCIENTIFIC PLC

Share Issue/Capital Change Jan 8, 2021

7734_dirs_2021-01-08_eb031cb9-ca68-4baa-9a16-e0414ce52c66.html

Share Issue/Capital Change

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 0597L

Judges Scientific PLC

08 January 2021

Press Release

Judges Scientific plc

("Judges Scientific")

Grant of Options

Judges Scientific announces that it has issued options over 60,000 new ordinary shares of 5 pence each in the Company ("Ordinary Shares") at an exercise price of £65.80, being the closing share price on 7 January 2021.

20,000 options have been awarded by the Remuneration Committee to each of the Executive Directors to retain and incentivise them. Vesting of the options after three years is subject to the achievement of an adjusted earnings per share target for 2021, with 10% compound growth in adjusted earnings per share over the target in 2022 and 2023 respectively, and to continued employment.

Director Number of options Option Scheme Vesting date Expiry date
David Cicurel 20,000 Unapproved 08/01/2024 07/01/2031
Brad Ormsby 20,000 Unapproved 08/01/2024 07/01/2031
Mark Lavelle 20,000 Unapproved 08/01/2024 07/01/2031

Ends -  

Judges Scientific
David Cicurel, CEO

Brad Ormsby, Group FD
Tel: +44 (0) 20 3829 6970
Shore Capital (Nominated Adviser & Joint Broker)
Stephane Auton

Edward Mansfield

Sarah Mather
Tel: +44 (0) 20 7408 4090
Liberum (Joint Broker)

Bidhi Bhoma

Euan Brown

Alma (Financial Public Relations)

Rebecca Sanders-Hewett

Justine James

Sam Modlin
Tel: +44 (0) 20 3100 2222 

Tel: +44 (0) 20 3405 0205

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

David Cicurel

2

Reason for the notification

a)

Position/status

Chief Executive Officer

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Judges Scientific plc

b)

LEI

2138004EXWWPTW1JOL31

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares in Judges Scientific plc

GB0032398678

b)

Nature of the transaction

Grant of Options

c)

Price(s) and volume(s)

Price(s) Volume(s)
6580p 20,000

d)

Aggregated information

- Aggregated volume

- Price

N/A

e)

Date of the transaction

08/01/2021

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Bradley Ormsby

2

Reason for the notification

a)

Position/status

Group Finance Director

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Judges Scientific plc

b)

LEI

2138004EXWWPTW1JOL31

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares in Judges Scientific plc

GB0032398678

b)

Nature of the transaction

Grant of Options

c)

Price(s) and volume(s)

Price(s) Volume(s)
6580p 20,000

d)

Aggregated information

- Aggregated volume

- Price

N/A

e)

Date of the transaction

08/01/2021

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Mark Lavelle

2

Reason for the notification

a)

Position/status

Chief Operating Officer

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Judges Scientific plc

b)

LEI

2138004EXWWPTW1JOL31

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares in Judges Scientific plc

GB0032398678

b)

Nature of the transaction

Grant of Options

c)

Price(s) and volume(s)

Price(s) Volume(s)
6580p 20,000

d)

Aggregated information

- Aggregated volume

- Price

N/A

e)

Date of the transaction

08/01/2021

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

Notes to editors: 

Judges Scientific plc (AIM: JDG), is a group focused on acquiring and developing companies in the scientific instrument sector .  The Group now consists of 19 businesses acquired since it was re-admitted to AIM in 2005.

The acquired companies are primarily UK-based with products sold worldwide to a diverse range of markets including: higher education institutions, the scientific communities, manufacturers and regulatory authorities.  The UK is a recognised centre of excellence for scientific instruments.  The Group companies hold five Queen's Awards for innovation and export.

The Group's companies predominantly operate in global niche markets, with long term growth fundamentals and resilient margins.

Judges Scientific maintains a policy of selectively acquiring businesses that generate sustainable profits and cash.  Shareholder returns are created through the repayment of debt, organic growth and dividends.

For further information, please visit  www.judges.uk.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHGCGDBIDGDGBI

Talk to a Data Expert

Have a question? We'll get back to you promptly.